Skip to content

Study on the Application of SLET in the Treatment of Severe Symblepharon

Study on the Application of SLET in the Treatment of Severe Symblepharon

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117295
Enrollment
Unknown
Registered
2026-01-22
Start date
2026-01-26
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acquired symblepharon

Interventions

Improved Surgical Group:Conventional surgical method plus Simple Limbal Epithelial Transplantation (SLET)
Surgical Control Group:Conventional Surgery

Sponsors

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. 18–65 years of age, any gender; 2. Severe symblepharon (symblepharon score: 19–27 points); 3. Limbal stem cell deficiency > 1/2 of the limbus; 4. No prior ocular surface reconstruction surgery,simple amniotic membrane transplantation allowed; 5. Interval from burn injury to enrollment > 1 year

Exclusion criteria

Exclusion criteria: 1. Infectious diseases (hepatitis B, syphilis, HIV, etc.); 2. Glaucoma, ocular hypertension, fundus lesions, or ophthalmic surgery within 6 months; 3. Systemic diseases (hepatic/renal insufficiency, CHD, hypertension, DM, etc.); 4. Hematological/hemorrhagic diseases, poor coagulation, anemia, malnutrition, low body weight; 5. Other autoimmune diseases, mental disorders; 6. Pregnancy or lactation; 7. Bilateral symblepharon, or limbal stem cell deficiency/unhealthy limbus in contralateral eye.

Design outcomes

Primary

MeasureTime frame
One-year recurrence rate after symblepharon surgery;

Secondary

MeasureTime frame
Best corrected visual acuity;corneal transparency;

Countries

China

Contacts

Public ContactChunyi Shao

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine

wujunshabu@126.com+86 139 1765 7601

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026